InVivo Therapeutics Holdings Corp. (OTC:NVIV) pushed forward on the development of its manufacturing capabilities with the appointment of biomedical engineer Phil Pereira.
As the company’s new director of manufacturing, Pereira will be responsible for overseeing scale-up, qualification and compliance efforts in the manufacture of InVivo’s lead product candidate, a novel, biocompatible polymer scaffolding device, at the company’s recently opened manufacturing and development facility, according to the company.
InVivo signed a lease for the Medford, Mass. facility last November after an October reverse merger netted the company $9 million.
The Cambridge, Mass.-based company is developing implantable treatments for acute spinal cord injury.
Prior to joining InVivo, Pereira served for seven years as senior manufacturing/product development engineer at Woburn, Mass.-based Intrinsic Therapeutics Inc., where he was responsible for overseeing and scaling up cGMP (current good manufacturing practice) for the company’s various products, including its polymer- and biomaterials-based products. “Phil brings valuable cGMP manufacturing experience to the team at an important time in our corporate development,” CEO Frank Reynolds said in prepared remarks.
Here’s the latest personnel changes from medical device, diagnostics and life science companies around the nation. For more recent hirings and firings, check out MassDevice’s compilation of the latest personnel moves.
- Great Basin Corp. hires key executives to prepare for commercial launch
Great Basin Corp., formerly known as Great Basin Scientific, Inc., a privately held life sciences company developing novel, point-of-care molecular diagnostic solutions, announced key appointments to its management team, including Sales, Marketing and R&D executives. These strategic hires—in addition to the company’s operational expansion into a new Salt Lake City headquarters—are supported by $12.1 million series A financing closed in 2010 and prepares Great Basin for the commercial launch of its rapid molecular diagnostic testing platform.
Read more - NanoString rounds out commercial management team with VPs of sales, marketing
NanoString Technologies Inc., a privately held life sciences company marketing a complete solution for detecting and counting large sets of target molecules in biological samples, announced it has rounded out its commercial management team with the hiring of Chris Grimley as Vice President of Marketing and Katherine Webster as Vice President of Worldwide Sales. Grimley and Ms. Webster will report to the company’s recently appointed Chief Commercial Officer, Barney Saunders, Ph.D.
Read more - Kendle promotes Stephen Cutler to CEO
Kendle Internaional Inc. (NSDQ:KNDL), a global full-service clinical research organization, announced that as part of a planned succession Senior Vice President and COO Stephen Cutler, PhD, will become the Company’s next President and CEO. Chairman and CEO Candace Kendle, PharmD, will continue to serve as Chairman. Assuming the role of Senior Vice President and COO from Dr. Cutler will be Jamie Macdonald, who brings 16 years of experience in the CRO industry to Kendle. Dr. Kendle, Dr. Cutler and Macdonald will assume their new roles May 1. Also effective May 1, Christopher Bergen will leave his position as Executive Vice President and CAO but will continue to serve on the Company’s Board of Directors.
Read more - Mirador taps Steve Gappa as VP of sales
Mirador Biomedical Inc., developer and manufacturer of the Compass family of medical devices, announced the addition of Steve Gappa as Vice President of Sales. Gappa brings 10 years in sales and management with Arrow International, a manufacturer of critical care and vascular access products. At Arrow, he was an inaugural member of the Chairman’s Club, repeatedly one of the top sales reps, and ultimately moved into management where he was three-time Regional Manager of the Year.
Read more
